The Center invited Dr. Andrew Mirelman, Research Fellow, the Center for Health Economics, the University of York, UK, as a guest speaker and held its 20th regular seminar/Hitotsubashi University International Seminar, on Wednesday, December 20, 2018.
Dr. Mirelman's presentation was based on the newest result of his research on sugar tax, which he is carrying on with Dr. Ryota Nakamura, Associate Professor, Hitotsubashi Institute for Advanced Study (HIAS), a member of the center.
|Dr. Ryota Nakamura, Associate Professor, HIAS, introducing Dr. Andrew Milelman
Dr. Andrew Mirelman responding a question
|During the presentation
|with members and adjunct members of the center
|Date & time
|December 20 (Wed.) 18:00-19:30
|HIAS Seminar Room (Faculty Building II, Room 517), Kunitachi West Campus, Hitotsubashi University
|Dr. Andrew Mirelman, Research Fellow, Center for Health Economics, University of York, UK
|“Accounting for equity in the assessment of fiscal policies for health”
Presentation was given in English
Andrew is a Research Fellow in the Global Health Economics team. He joined the Centre in the summer of 2014 and has a BSc in Biomedical Engineering from the University of Virginia, an MPH from Johns Hopkins Bloomberg School of Public Health (JHSPH) and a PhD in the Health Systems within the Department of International Health at JHSPH. His PhD dissertation is titled: “The Economics of Non-Communicable Diseases in Rural Bangladesh” and explores health inequalities and the economic impacts from non-communicable disease in a rural adult population.
Andrew’s work focuses on health systems and economic issues in low and middle-income countries. He has worked in Bangladesh, Peru and China on non-communicable diseases and has a particular interest in population and burden modelling as well as economic evaluation of preventive interventions. Additionally, he has also been a part of the Decade of Vaccines economics working group through Johns Hopkins’ International Vaccine Access Center (IVAC) and has contributed to work on valuing the benefits of childhood immunization in low and middle-income countries.